Preventive Healthcare Technologies, Products and Markets
December 17, 2009
Wellesley, Mass. – According to a new technical market research report, PREVENTIVE HEALTHCARE TECHNOLOGIES, PRODUCTS, AND MARKETS (HLC070A) from BCC Research (www.bccresearch.com), the global market for new preventive healthcare technologies is valued at an estimated $11 billion in 2009, but is expected to increase to nearly $16.2 billion in 2014, for a 5-year compound annual growth rate (CAGR) of 8.2%.
The largest segment of the market, products, is projected to reach $12.2 billion in 2014, after increasing at a CAGR of 7.4% from the 2009 value of $8.5 billion.
The services segment is estimated at $2.4 billion in 2009, and is expected to reach $4 billion in 2014, for a 5-year CAGR of 10.8%.
![]()
Preventive healthcare is likely to be an important component of any plan to restructure the U.S. healthcare system. At present, between 4% and 8% of the $2.4 trillion the U.S. spends annually on healthcare (i.e., $96 billion to $192 billion) goes for preventive care.
Broadly defined, preventive healthcare includes everything from over-the-counter (OTC) products designed to help users curb smoking or overeating to advanced genetic testing to identify a predisposition to certain cancers or other health problems. This report, however, focuses on a group of advanced preventive healthcare technologies and services.
Some of these technologies, such as certain vaccines, are decades old, while others (e.g., cytomics) are still largely at the experimental stage for clinical applications. This report generally focuses on new or emerging technologies, without being too rigid about what constitutes a “new” technology. Areas of particular interest include genomics, proteomics, cytomics, radiology, nanotechnology, informatics, and automation.
The report is intended especially for vendors of preventive healthcare-related products and services, as well as government agencies, healthcare policy analysts, and others seeking to understand the cost and preconditions for success of preventive healthcare initiatives.
Preventive Healthcare Technologies, Products and Markets( HLC070A )
Publish Date: Oct 2009
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Health Maintenance
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Long-Term Care and Home Healthcare Technology Market to Reach $64.8 Billion by 2030 as Aging Demographics and Remote Monitoring Reshape Care Delivery
- Thermo Fisher Scientific Inc.: BCC Research Releases Comprehensive 360° Company Analysis
- Healthcare Predictive Analytics Market to Grow at 24.7% CAGR Through 2030
- mHealth Technologies Market Poised for 17.1% CAGR Growth Through 2030
Reports from Health Maintenance
Recent News
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand